170 related articles for article (PubMed ID: 35096932)
1. Nutritional Risk Index Predicts Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy.
Chen L; Qi Y; Kong X; Su Z; Wang Z; Wang X; Du Y; Fang Y; Li X; Wang J
Front Nutr; 2021; 8():786742. PubMed ID: 35096932
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator.
Chen L; Bai P; Kong X; Huang S; Wang Z; Wang X; Fang Y; Wang J
Front Cell Dev Biol; 2021; 9():656741. PubMed ID: 33859986
[TBL] [Abstract][Full Text] [Related]
3. Preoperative Breast Immune Prognostic Index as Prognostic Factor Predicts the Clinical Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
Chen L; Kong X; Huang S; Su Z; Zhu M; Fang Y; Zhang L; Li X; Wang J
Front Immunol; 2022; 13():831848. PubMed ID: 35320931
[TBL] [Abstract][Full Text] [Related]
4. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator.
Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
Cancer Manag Res; 2020; 12():1543-1567. PubMed ID: 32184659
[TBL] [Abstract][Full Text] [Related]
6. Nutritional Risk Index as a Prognostic Factor Predicts the Clinical Outcomes in Patients With Stage III Gastric Cancer.
Song H; Sun H; Yang L; Gao H; Cui Y; Yu C; Xu H; Li L
Front Oncol; 2022; 12():880419. PubMed ID: 35646673
[TBL] [Abstract][Full Text] [Related]
7. Controlling Nutritional Status (CONUT) as a Novel Postoperative Prognostic Marker in Breast Cancer Patients: A Retrospective Study.
Zhu M; Chen L; Kong X; Wang X; Ren Y; Liu Q; Li X; Fang Y; Wang J
Biomed Res Int; 2022; 2022():3254581. PubMed ID: 36531650
[TBL] [Abstract][Full Text] [Related]
8. The Systemic Inflammation Response Index as an Independent Predictor of Survival in Breast Cancer Patients: A Retrospective Study.
Zhu M; Chen L; Kong X; Wang X; Fang Y; Li X; Wang J
Front Mol Biosci; 2022; 9():856064. PubMed ID: 35295846
[TBL] [Abstract][Full Text] [Related]
9. Nutritional assessment and prognosis of oral cancer patients: a large-scale prospective study.
Bao X; Liu F; Lin J; Chen Q; Chen L; Chen F; Wang J; Qiu Y; Shi B; Pan L; Lin L; He B
BMC Cancer; 2020 Feb; 20(1):146. PubMed ID: 32087695
[TBL] [Abstract][Full Text] [Related]
10. Construction of a comprehensive nutritional index and comparison of its prognostic performance with the PNI and NRI for survival in older patients with nasopharyngeal carcinoma: a retrospective study.
Duan YY; Deng J; Su DF; Li WQ; Han Y; Li ZX; Huan XZ; Zhu SH; Yang QL; Hu W; Xin MZ; Tang LQ; Mai HQ; Fan YY; He Y
Support Care Cancer; 2021 Sep; 29(9):5371-5381. PubMed ID: 33686519
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers treated with neoadjuvant chemotherapy.
Yang X; Rao J; Yang W; Shui R
Target Oncol; 2018 Dec; 13(6):757-767. PubMed ID: 30406444
[TBL] [Abstract][Full Text] [Related]
12. Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer.
Miglietta F; Dieci MV; Tsvetkova V; Griguolo G; Vernaci G; Menichetti A; Faggioni G; Giarratano T; Mioranza E; Genovesi E; Cumerlato E; Bottosso M; Saibene T; Michieletto S; Lo Mele M; Conte P; Guarneri V
Oncologist; 2020 Sep; 25(9):e1355-e1362. PubMed ID: 32618068
[TBL] [Abstract][Full Text] [Related]
13. Development of a nomogram for predicting survival of breast cancer patients with neoadjuvant chemotherapy: a dynamic analysis for systemic inflammation response index.
Huang W; Xiong Z; Zhong W; Zhang C; Feng J; Wang X
Gland Surg; 2023 Nov; 12(11):1459-1474. PubMed ID: 38107499
[TBL] [Abstract][Full Text] [Related]
14. Elevated Controlling Nutritional Status (CONUT) Score is Associated with Poor Long-term Survival in Patients with Low-grade Soft-tissue Sarcomas Treated with Surgical Resection.
Liang Y; Hou T; Que Y; Zhao B; Xiao W; Zhang X; Zhou Z
Clin Orthop Relat Res; 2019 Oct; 477(10):2287-2295. PubMed ID: 31107315
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of factors related to the prognostic benefit of neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced ovarian cancer].
Wang DF; Zhang GN; Peng CR; Shi Y; Shi XW
Zhonghua Fu Chan Ke Za Zhi; 2021 Jun; 56(6):385-392. PubMed ID: 34154313
[No Abstract] [Full Text] [Related]
16. Prognostic value of combined preoperative fibrinogen-albumin ratio and platelet-lymphocyte ratio score in patients with breast cancer: A prognostic nomogram study.
Zheng Y; Wu C; Yan H; Chen S
Clin Chim Acta; 2020 Jul; 506():110-121. PubMed ID: 32156604
[TBL] [Abstract][Full Text] [Related]
17. Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy.
Chen L; Hao Y; Zhu L; Li S; Zuo Y; Zhang Y; Song H; Xue Y
Onco Targets Ther; 2017; 10():4007-4016. PubMed ID: 28860808
[TBL] [Abstract][Full Text] [Related]
18. Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response.
Resende U; Cabello C; Ramalho SOB; Zeferino LC
BMC Cancer; 2019 Jun; 19(1):601. PubMed ID: 31208353
[TBL] [Abstract][Full Text] [Related]
19. Preoperative nutritional status assessment predicts postoperative outcomes in patients with surgically resected non-small cell lung cancer.
Ramos R; Nadal E; Peiró I; Masuet-Aumatell C; Macia I; Rivas F; Rosado G; Rodriguez P; Ureña A; Padrones S; Aso S; Deniz C; Navarro A; Escobar I
Eur J Surg Oncol; 2018 Sep; 44(9):1419-1424. PubMed ID: 29685760
[TBL] [Abstract][Full Text] [Related]
20. The Systemic Immune-Inflammation Index is an Independent Predictor of Survival in Breast Cancer Patients.
Zhu M; Chen L; Kong X; Wang X; Li X; Fang Y; Wang J
Cancer Manag Res; 2022; 14():775-820. PubMed ID: 35241935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
